How The Vertex Pharmaceuticals (VRTX) Story Is Shifting Toward Nephrology And Beyond Cystic Fibrosis [Yahoo! Finance]
Vertex Pharmaceuticals Incorporated (VRTX)
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vrtx.com
Company Research
Source: Yahoo! Finance
Vertex Pharmaceuticals now carries a fair value estimate of US$547.72, compared with the prior US$504.04, as analysts refresh their assumptions around the stock. Much of that shift is being tied to a stronger narrative around the company's nephrology platform, recent povetacicept data in IgA nephropathy, and a cluster of price target lifts and rating upgrades. In the following sections, you will see how this evolving analyst story could matter for how you track Vertex and respond to future updates. Stay updated as the Fair Value for Vertex Pharmaceuticals shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on Vertex Pharmaceuticals. What Wall Street Has Been Saying ?? Bullish Takeaways Multiple firms, including Oppenheimer, BofA, Morgan Stanley, Citi, H.C. Wainwright, Barclays, Truist, Wells Fargo and others, have lifted price targets on Vertex into a US$525 to US$641 range, reflecting refreshed models after t
Show less
Read more
Impact Snapshot
Event Time:
VRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
News
- Is Vertex Pharmaceuticals Incorporated (VRTX) A Good Stock To Buy Now? [Yahoo! Finance]Yahoo! Finance
- How Vertex's IgA Nephropathy Data and Accelerated FDA Pathway At Vertex Pharmaceuticals (VRTX) Has Changed Its Investment Story [Yahoo! Finance]Yahoo! Finance
- My Top 3 Drug Stocks for March 2026 [Yahoo! Finance]Yahoo! Finance
- Assessing Vertex Pharmaceuticals (VRTX) Valuation After Positive RAINIER Trial Update And Accelerated IgAN Filing [Yahoo! Finance]Yahoo! Finance
- Block upgraded, Starbucks downgraded: Wall Street's top analyst calls [Yahoo! Finance]Yahoo! Finance
VRTX
Earnings
- 2/12/26 - Beat
VRTX
Sec Filings
- 3/17/26 - Form 4
- 3/13/26 - Form 4
- 3/13/26 - Form 144
- VRTX's page on the SEC website